Mepinaest Purum (Mepivacaine Hydrochloride)

Mepivacaine works by blocking voltage‑gated sodium channels on nerve membranes. This blockade prevents the initiation and propagation of action potentials, effectively stopping nerve impulse transmission. The result is a temporary loss of sensation in the area where the drug is injected.

The appropriate dose of Mepinaest Purum is determined by the prescribing clinician based on the specific procedure, patient characteristics, and maximum recommended limits. Healthcare professionals calculate the dose to achieve effective anesthesia while minimizing the risk of toxicity.

Safety data for Mepinaest Purum in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and only under the guidance of a qualified healthcare provider.

To order Mepinaest Purum, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Both Mepinaest Purum (mepivacaine) and lidocaine are amide‑type local anesthetics. Mepivacaine typically has a slightly longer duration of action and a lower pKa, which may result in a faster onset in some tissues. Choice between them depends on the clinical situation, desired duration, and individual patient response.

Mepinaest Purum should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct light. Ensure the container is tightly sealed and avoid exposure to extreme temperatures to maintain product stability.

Mepinaest Purum is administered by a qualified healthcare professional via infiltration injection. The solution is injected directly into the tissue surrounding the target nerve or surgical site, allowing rapid onset of local anesthesia.

Serious risks include allergic reactions such as anaphylaxis, cardiovascular toxicity (e.g., hypotension, arrhythmias, cardiac arrest), and central nervous system toxicity leading to seizures or loss of consciousness. Immediate medical attention is required if any of these symptoms occur.

Mepinaest Purum should not be used in patients with a known hypersensitivity to mepivacaine, other amide‑type local anesthetics, or any of its excipients. It is also contraindicated in individuals with severe cardiac conduction disorders, uncontrolled arrhythmias, or those for whom the risk of systemic toxicity outweighs the benefit.